featured
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial
JAMA Dermatol 2020 Apr 08;[EPub Ahead of Print], A Blauvelt, CL Leonardi, M Gooderham, KA Papp, S Philipp, JJ Wu, A Igarashi, M Flack, Z Geng, T Wu, A Camez, D Williams, RG LangleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.